FR2609M - Nouveau médicament pour le traitement des infections staphylococciques et streptococciques. - Google Patents

Nouveau médicament pour le traitement des infections staphylococciques et streptococciques.

Info

Publication number
FR2609M
FR2609M FR930139A FR930139A FR2609M FR 2609 M FR2609 M FR 2609M FR 930139 A FR930139 A FR 930139A FR 930139 A FR930139 A FR 930139A FR 2609 M FR2609 M FR 2609M
Authority
FR
France
Prior art keywords
staphylococcal
treatment
new drug
streptococcal infections
streptococcal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR930139A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharmacal Co filed Critical Norwich Pharmacal Co
Application granted granted Critical
Publication of FR2609M publication Critical patent/FR2609M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR930139A 1962-04-02 1963-04-02 Nouveau médicament pour le traitement des infections staphylococciques et streptococciques. Active FR2609M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US184490A US3138593A (en) 1962-04-02 1962-04-02 4, 5-dihydro-6-(5-nitro-2-furyl)-as-triazinor pyridazin-3-(2h)-one

Publications (1)

Publication Number Publication Date
FR2609M true FR2609M (fr) 1964-06-22

Family

ID=22677090

Family Applications (1)

Application Number Title Priority Date Filing Date
FR930139A Active FR2609M (fr) 1962-04-02 1963-04-02 Nouveau médicament pour le traitement des infections staphylococciques et streptococciques.

Country Status (8)

Country Link
US (1) US3138593A (fr)
BE (1) BE630438A (fr)
CH (1) CH417617A (fr)
DE (1) DE1185618B (fr)
ES (1) ES286659A1 (fr)
FR (1) FR2609M (fr)
GB (1) GB1005041A (fr)
NL (1) NL291027A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3335140A (en) * 1965-02-26 1967-08-08 Norwich Pharma Co 2-methyl-6-(5-nitro-2-furyl)-3-thio-as-triazine-3, 5(4h)-dione
FR1518600A (fr) * 1966-03-07 1968-03-29 Procédé pour la fabrication industrielle de l'hydroxocobalamine
US3506656A (en) * 1966-10-22 1970-04-14 Boehringer Mannheim Gmbh Triazolo-tetrazolo-pyridazine derivatives
US3494921A (en) * 1968-08-29 1970-02-10 Dow Chemical Co 1,4-disubstituted pyridazino(4,5-d) pyridazines
US3715356A (en) * 1971-02-19 1973-02-06 Pfizer 1-phenyl-6-azacytosines as coccidiostats
BE793629A (fr) * 1972-01-03 1973-07-03 Upjohn Co Nouveaux derives de benzodiazepines et leur preparation
DE2202745A1 (de) * 1972-01-21 1973-07-26 Boehringer Mannheim Gmbh Nitrofuryl-triazolo eckige klammer auf 4,3-b eckige klammer zu-pyridazin-carbonsaeurederivate
DE2202744A1 (de) * 1972-01-21 1973-07-26 Boehringer Mannheim Gmbh Nitrofuryl-triazolo eckige klammer auf 4,3-b eckige klammer zu-pyridazin-amide
US3879386A (en) * 1973-06-22 1975-04-22 Scott & Sons Co O M Amino substituted 1,2,4-triazinones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL104211C (fr) * 1958-02-28
AT217463B (de) * 1960-02-23 1961-10-10 Norwich Pharma Co Verfahren zur Herstellung des neuen 6-(5'-Nitro-2'-furyl)-azauracils

Also Published As

Publication number Publication date
NL291027A (fr)
DE1185618B (de) 1965-01-21
US3138593A (en) 1964-06-23
GB1005041A (en) 1965-09-22
CH417617A (de) 1966-07-31
BE630438A (fr)
ES286659A1 (es) 1963-08-16

Similar Documents

Publication Publication Date Title
FR1444M (fr) Nouveau médicament notamment pour le traitement des irrégularités et des insuffisances ovariennes.
FR2609M (fr) Nouveau médicament pour le traitement des infections staphylococciques et streptococciques.
FR362M (fr) Nouveau médicament pour le traitement des infections staphylococciques et des salmonelloses.
FR365M (fr) Nouveau médicament pour le traitement des infections staphylococciques et streptococciques.
FR1438M (fr) Nouveau médicament efficace dans le traitement de l'athérosclérose.
FR2510M (fr) Nouveau médicament utilisable pour le traitement des infections staphylococciques et analogues.
FR3875M (fr) Nouveau médicament convenant notamment au traitement des infections tuberculeuses.
FR2193M (fr) Nouveau médicament pour le traitement des maladies infectieuses.
FR363M (fr) Nouveau médicament pour le traitement des trypanosomoses, des salmonelloses et des infections pénicillo-résistantes.
FR385M (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
FR2802M (fr) Nouveau médicament notamment pour le traitement des irrégularités et des insuffisances ovariennes.
FR2413M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
FR33F (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
FR3187M (fr) Nouveau médicament notamment pour le traitement des irrégularites et des insuffisances ovariennes.
FR3395M (fr) Nouveau médicament notamment pour le traitement des états neurodépressifs et des psychoses d'anxiété.
FR1729M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
FR1259M (fr) Nouveau médicament notamment pour le traitement des infections dues a des staphylocoques.
FR23F (fr) Nouveau médicament notamment pour le traitement des infections dues a des staphylocoques.
FR1982M (fr) Nouvelles alcanamides-hydrazines n-substituées, utilisables notamment dans le traitement des infections staphylococciques rebelles.
FR364M (fr) Nouveau médicament pour le traitement des salmonelloses, staphylococcies et trichomonoses.
FR1172M (fr) Nouveau médicament notamment pour le traitement des irrégularités et des insuffisances ovariennes.
FR1804M (fr) Nouveau médicament notamment pour le traitement des infections d'origine microbienne.
FR28F (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
FR3096M (fr) Nouveau médicament notamment pour le traitement des états d'adynamie.
FR3744M (fr) Médicaments pour le traitement des affections psychiatriques.